Ventana to Develop CDx for Merck KGaA | GenomeWeb

NEW YORK (GenomeWeb) – Ventana Medical Systems today said that it will collaborate with Merck KGaA on a companion diagnostic test for an undisclosed therapeutic target.

According to the firms, Ventana will develop and validate the CDx test for future clinical studies. Further details of the collaboration were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: researchers explore the transfer of host genetic material into viruses, and more.

It's too difficult to correct or retract a flawed scientific paper, researchers write in Nature.

A proposed bill would require NSF to only fund research that's in "the national interest."

Australia's Commonwealth Scientific and Industrial Research Organisation plans to eliminate up to 350 jobs.

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.